Fluzone High-Dose
Payments companies reported to CMS as associated with Fluzone High-Dose. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fluzone High-Dose, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fluzone High-Dose
These are the largest totals companies reported as associated with Fluzone High-Dose. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Sebeny | Newburyport, MA | Infectious Disease | $8,412.93 |
| John Russell | Jenkintown, PA | Family Medicine | $7,943.38 |
| Audrey Stevenson | Phoenix, AZ | Family | $5,858.39 |
| Vincent Hsu | Orlando, FL | Infectious Disease | $4,951.07 |
| Yoav Golan | Boston, MA | Infectious Disease | $4,060.00 |
| Rebecca Young | Long Beach, CA | Family Medicine | $226.31 |
| Cherie Garcia | Lakewood, CA | Internal Medicine | $203.22 |
| Elliot Miller | Libertyville, IL | Internal Medicine | $195.14 |
| Mark Riederman | Libertyville, IL | Internal Medicine | $195.14 |
| Gawu Kamara Bankole | Royersford, PA | Family Medicine | $171.32 |
Prescribed Fluzone High-Dose?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.